| Name | Title | Contact Details |
|---|
Mission Statement Each day we make a personal commitment to go beyond - build deeper relationships, provide innovative solutions, work collaboratively as a team, serve our community, and be active stewards for the future of Glenn Burdette. Commitment to Service Accounting is often called a numbers business, but we view it as a service business. We are deeply committed to serving our clients, who are responsible for our success; our employees, who are the heart and soul of our firm; and our community, where we make our homes, raise our families and participate in activities that enrich our lives. Dedication to Clients Our goal is to go above and beyond for our clients, creatively applying our expertise and experience to meet their individual needs. We help them seize opportunities today, and offer solutions for their challenges ahead. We serve a diverse base of large, middle-market and small owner-managed businesses in a wide range of industries, and we are also proud to serve a number of nonprofit organizations, governmental agencies and individuals. Loyalty to Employees We foster an environment where hard work and client service are rewarded. In 2000, Glenn Burdette became the first CPA firm in California to become employee owned, developing an authentic investment in the professional development and personal success of our team. We believe that happy employees make the most satisfied clients. Involvement in Community Community service is integral to the culture of Glenn Burdette. Our employees serve on local nonprofit boards, and are active in chambers of commerce and service clubs from Santa Maria to Paso Robles.
Fisher Barton is a prominent manufacturing company with over 50 years of experience, founded in 1973 by metallurgist Richard L. Wilkey. Headquartered in Watertown, Wisconsin, the company has grown to employ more than 900 people worldwide. It operates as a group of independent manufacturing companies, including Fisher Barton Blades and Thermal Spray Technologies. The company specializes in materials and surface engineering, offering a diverse range of products such as industrial knives, lawnmower blades, agricultural knives, and thermal spray coatings. Fisher Barton is recognized for its metallurgical expertise, supported by an in-house lab that enhances product development and quality assurance. The company serves major clients, including John Deere, and has been acknowledged for its excellence in supply and innovation. Fisher Barton continues to focus on technological advancements and employee development to maintain its leadership in the industry.
Our dedicated attorneys with impressive trial experience and impeccable reputations represent clients nationwide and can help change your life by legalizing your status so you can remain here with your family, for good. Our mission is to bring compassion back to law by protecting client rights, representing and fighting for what our clients deserve. Far too often we see genuine, good people silenced because they dont have the resources they need to see their case through. Nothing can feel more intimidating than sorting through paperwork, keeping track timelines, and navigating the complex immigration system. Our attorneys advocate ruthlessly for your rights with compassionate representation. We anticipate the needs of our clients and are well-versed in proactive planning if you or a loved one are in need immigration support. As our client, you will always be our top priority. That is our promise.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.